Rodrigo Damith, Rathnapala Amila, Senaratne Wijitha
National Hospital for Respiratory Diseases, Welisara, Sri Lanka.
J Med Case Rep. 2015 Apr 29;9:93. doi: 10.1186/s13256-015-0574-z.
Therapeutic total lung lavage under general anesthesia is the current mainstay of treatment for pulmonary alveolar proteinosis, which is a rare lung disease characterized by alveolar accumulation of surfactant. Therapeutic limited bronchoalveolar lavage is considered an alternative treatment to conventional total lung lavage.
A 61-year-old, previously healthy, Sri Lankan Moor woman presented to our facility with progressively worsening difficulty in breathing and persistent dry cough for one year. Her respiratory examination revealed bibasal fine end-inspiratory crepitations. A chest radiograph showed bilateral mid and lower zone alveolar interstitial shadows and a high-resolution computed tomography scan of her chest revealed septal thickening with ground-glass shadows more on mid and lower zones bilaterally. A diagnostic bronchoalveolar lavage fluid analysis revealed diastase-resistant protein clumps in periodic acid Schiff stain. The diagnosis was made as pulmonary alveolar proteinosis. An arterial blood gas analysis performed prior to intervention revealed a significant hypoxia (partial pressure of oxygen - 64 mmHg) with alveolar-arterial gradient was 35.4 mmHg. Therapeutic limited bronchoalveolar lavage was arranged and her right and her left lung were lavaged separately in two sessions done two weeks apart under local anesthesia. Our patient had significant clinical improvement and resolution of the bilateral septal thickening with minimal resolution of the ground-glass opacities in a repeat high-resolution computed tomography scan done two weeks later. Subsequently, a total lung lavage under general anesthesia was also done, which improved her dyspnea and arterial hypoxemia.
Therapeutic limited bronchoalveolar lavage can be successfully performed as an interval bridging procedure, as a 'prewash', prior to conventional total lung lavage for pulmonary alveolar proteinosis.
全身麻醉下的治疗性全肺灌洗是肺泡蛋白沉积症目前的主要治疗方法,肺泡蛋白沉积症是一种罕见的肺部疾病,其特征是肺泡表面活性物质积聚。治疗性局限性支气管肺泡灌洗被认为是传统全肺灌洗的替代治疗方法。
一名61岁、既往健康的斯里兰卡摩尔族女性因进行性加重的呼吸困难和持续干咳一年就诊于我院。她的呼吸检查显示双肺底部吸气末细湿啰音。胸部X线片显示双侧中、下肺野肺泡间质阴影,胸部高分辨率计算机断层扫描显示双侧中、下肺野间隔增厚伴磨玻璃影。诊断性支气管肺泡灌洗液体分析显示高碘酸希夫染色中有抗淀粉酶蛋白团块。诊断为肺泡蛋白沉积症。干预前进行的动脉血气分析显示严重缺氧(氧分压-64mmHg),肺泡-动脉氧分压差为35.4mmHg。安排了治疗性局限性支气管肺泡灌洗,并在局部麻醉下分两次相隔两周分别对她的右肺和左肺进行灌洗。我们的患者临床症状有显著改善,两周后重复进行的高分辨率计算机断层扫描显示双侧间隔增厚明显缓解,磨玻璃影稍有缓解。随后,还进行了全身麻醉下的全肺灌洗,这改善了她的呼吸困难和动脉低氧血症。
治疗性局限性支气管肺泡灌洗可作为肺泡蛋白沉积症传统全肺灌洗前的一种间隔桥接程序,即“预灌洗”,成功实施。